Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksALBK.L Regulatory News (ALBK)

  • There is currently no data for ALBK

AIB - CEBS Stress Test

23 Jul 2010 17:41

RNS Number : 8757P
Allied Irish Banks PLC
23 July 2010
 



 

 

 

For Immediate Release

23rd July 2010

 

 

 

AIB - CEBS STRESS TEST

 

 

Allied Irish Banks, p.l.c. ("AIB") [NYSE: AIB] welcomes today's earlier announcements of the EU wide stress testing exercise co-ordinated by the Committee of European Banking Supervisors (CEBS) in cooperation with the European Central Bank and under the supervision of the Central Bank and Financial Regulator. The now published results confirm that in all scenarios tested AIB exceeds the threshold of 6% Tier 1 capital adequacy ratio agreed exclusively for the purpose of the stress testing exercise. As part of the disclosure process, AIB agreed to outline its sovereign exposures as at 31st March 2010 and this information is appended.

 

For ease of reference, the results of the AIB stress test are also appended.

 

 

-ENDS-

 

 

For further information please contact:-

Alan Kelly

Catherine Burke

General Manager, Corporate Services

Head of Corporate Relations and Communications

AIB Group

AIB Group

Dublin

Dublin

Tel: +353-1-6412162

Tel: +353-1-6413894

email: alan.j.kelly@aib.ie

email: catherine.e.burke@aib.ie

Allied Irish Banks plc - July 2010 Stress Test Results

 

·; Allied Irish Banks plc (AIB) was subject to the 2010 EU-wide stress testing exercise coordinated by the Committee of European Banking Supervisors (CEBS), in cooperation with the European Central Bank (ECB), and under the supervision of The Central Bank and Financial Regulator. AIB acknowledges the outcomes of the EU-wide stress tests.

 

·; This stress test complements the risk management procedures and regular stress testing programmes set up in AIB under the Pillar 2 framework of the Basel II, CRD requirements and the 'Implementation of the CRD, 28 December 2008'. It was also additional to the Central Bank and Financial Regulator's Prudential Capital Assessment Review (PCAR), the results of which were announced on 30 March 2010.

 

·; The exercise was conducted using the scenarios, methodology and key assumptions provided by CEBS (see the aggregate report published on the CEBS website). As a result of the assumed shock under the adverse scenario, the estimated consolidated Tier 1 capital ratio would change to 7.2% in 2011 compared to 7.0% as of end of 2009. An additional sovereign risk scenario would have a further impact of 0.70 of a percentage point on the estimated Tier 1 capital ratio, bringing it to 6.5% at the end of 2011, compared with the CRD regulatory minimum of 4%.

 

·; The results of the stress suggest a buffer of 352 EUR mln of the Tier 1 capital would exist at 31 December 2011 against the threshold of 6% of Tier 1 capital adequacy ratio agreed exclusively for the purposes of this exercise. This threshold should by no means be interpreted as a regulatory minimum (the regulatory minimum for the Tier 1 capital ratio is set to 4%), nor as a capital target reflecting the risk profile of the institution determined as a result of the supervisory review process in Pillar 2 of the CRD.

 

·; AIB has held discussions of the results of the stress test with its supervisor theCentral Bank and Financial Regulator. To be clear AIB's capital requirements resulting from the PCAR announced on 30 March 2010 were:

(1) An additional €7.396bn of equity capital to meet the base case target of 7% equity, before taking account of projected asset disposals, and

(2) €4.865bn of Core Tier 1 capital, less any equity generated under paragraph 1 excluding conversion of preference shares held by the Government, to meet the base case target of 8% Core Tier 1. This additional Core Tier 1 capital will also satisfy AIB's stress case target of 4% Core Tier 1.

 

AIB submitted its capital plan to the Central Bank and Financial Regulator by the 30 April 2010, as required under the PCAR, which details AIB's plans to raise the PCAR capital requirements by the 31 December 2010, as required, through a combination of equity raising and asset disposals.

 

·; The stress test was carried out under a number of key common simplifying assumptions (e.g. constant balance sheet, uniform treatment of securitisation exposures). Therefore, the information should in no way be construed as a forecast nor should it be taken as an update to capital plans. Consequently the numbers below may differ from numbers published previously by AIB. In addition, where the information does not reconcile to previously published information (e.g. annual statements or capital plans), this is a result of supervisory adjustments applied as part of the methodology of the stress test. In the interpretation of the outcome of the exercise, it is imperative to differentiate between the results obtained under the different scenarios developed for the purposes of the EU-wide exercise. The results of the adverse scenario should not be considered as representative of the current situation or possible present capital needs. A stress testing exercise does not provide forecasts of expected outcomes since the adverse scenarios are designed as "what-if" scenarios including plausible but extreme assumptions, which are therefore not very likely to materialise. Different stresses may produce different outcomes depending on the circumstances of each institution.

 

[1] Directive EC/2006/48 - Capital Requirements Directive (CRD)as implemented by SI 660 and 661 of 2006

2 CB & FR

3 See: http://www.c-ebs.org/EU-wide-stress-testing.aspx

AIB - Individual Results

At 31st December 2009

EUR mln

Total Tier 1 capital

8,542

Total regulatory capital

12,316

Total risk weighted assets*

121,605

Pre-impairment income (including operating expenses)

2,294

Impairment losses on financial assets in the banking book

-5,380

1 yr Loss rate on Corporate exposures (%)

4.60%

1 yr Loss rate on Retail exposures (%)4

0.66%

Tier 1 ratio (%)

7.0%

 

Outcomes of stress test scenarios

The stress test was carried out under a number of key common simplifying assumptions (e.g. constant balance sheet, uniform treatment of securitisation exposures). Therefore, the information relative to the benchmark scenarios is provided only for comparison purposes and should in no way be construed as a forecast.

 

Benchmark scenario at 31 December 20115

EUR mln

Total Tier 1 capital after the benchmark scenario

6,838

Total regulatory capital after the benchmark scenario

11,175

Total risk weighted assets after the benchmark scenario

72,313

Tier 1 ratio (%) after the benchmark scenario

9.5%

 

Adverse scenario at 31 December 20115

EUR mln

Total Tier 1 capital after the adverse scenario

5,305

Total regulatory capital after the adverse scenario

9,642

Total risk weighted assets after the adverse scenario

73,771

2 yr cumulative pre-impairment income after the adverse scenario (including operating expenses)

901

2 yr cumulative impairment losses on financial assets in the banking book after the adverse scenario5

-9,829

2 yr cumulative losses on trading book after the adverse scenario5

-20

2 yr Loss rate on Corporate exposures (%)after the adverse scenario4,5

6.11%

2 yr Loss rate on Retail exposures (%)after the adverse scenario4,5

4.31%

Tier 1 ratio after the adverse scenario (%)

7.2%

 

Additional sovereign shock on the adverse scenario at 31 December 2011

EUR mln

Additional impairment losses on the banking book after the sovereign shock5

-606

Additional losses on sovereign exposures in the trading book after the sovereign shock5

-36

2 yr Loss rate on Corporate Exposures after the adverse scenario + sovereign shock (%)4,5,

6.38%

2 yr Loss rate on Retail exposures after the adverse scenario + sovereign shock (%)4,5,6

4.94%

Tier 1 ratio after the adverse scenario + sovereign shock (%)

6.5%

Additional capital needed to reach 6% Tier 1 ratio under adverse scenario + additional sovereign shock, at the end of 2011

Nil

(surplus of 352)

*Inclusive of CRD transitional floor adjustments

4 Impairment losses as a % of corporate/retail exposures in AFS, HTM, and loans and receivables portfolios

5 Cumulative for 2010 and 2011

6 On the basis of losses estimated under both the adverse scenario and the additional sovereign shock

 

AIB - Group Exposures to central and local governments on a consolidated basis

 

Reporting Date

31 March 2010

 

EUR mln

Gross exposures

(net of impairment)

Of which

Banking Book

Of which

Trading Book

Net exposures

(net of impairment)

Austria

90

90

0

90

Belgium

66

66

0

66

Bulgaria

0

0

0

0

Cyprus

0

0

0

0

Czech Republic

0

0

0

0

Denmark

50

50

0

50

Estonia

0

0

0

0

Finland

25

25

0

25

France

845

845

0

845

Germany

525

525

0

525

Greece

41

41

0

41

Hungary

71

71

0

71

Iceland

0

0

0

0

Ireland

4,136

4,136

0

4,136

Italy

671

671

0

671

Latvia

0

0

0

0

Liechtenstein

0

0

0

0

Lithuania

0

0

0

0

Luxembourg

0

0

0

0

Malta

0

0

0

0

Netherlands

228

228

0

228

Norway

0

0

0

0

Poland

1,050

1,050

0

1,050

Portugal

257

257

0

257

Romania

0

0

0

0

Slovakia

0

0

0

0

Slovenia

0

0

0

0

Spain

391

391

0

391

Sweden

30

30

0

30

United Kingdom

1,088

1,088

0

1,088

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCRJMFTMBJTBLM
Date   Source Headline
23rd Mar 20094:55 pmRNSDirector/PDMR Shareholding
23rd Mar 20094:54 pmRNSDirector/PDMR Shareholding
19th Mar 200912:33 pmRNSMM - Cancellation Notice
19th Mar 20099:47 amRNSAnnual Report and Accounts on Form 20-F
12th Mar 20093:01 pmRNSDirector/PDMR Shareholding
12th Mar 20091:32 pmRNSAmendment to banking facilities update
11th Mar 20094:20 pmRNSDirector/PDMR Shareholding
3rd Mar 20093:47 pmRNSDirector/PDMR Shareholding
3rd Mar 20093:45 pmRNSDirector/PDMR Shareholding
3rd Mar 20093:41 pmRNSDirector/PDMR Shareholding
3rd Mar 20093:39 pmRNSDirector/PDMR Shareholding
3rd Mar 20093:36 pmRNSDirector/PDMR Shareholding
3rd Mar 20093:36 pmRNSDirector/PDMR Shareholding
3rd Mar 20093:31 pmRNSDirector/PDMR Shareholding
3rd Mar 20093:30 pmRNSDirector/PDMR Shareholding
3rd Mar 200911:05 amRNSHolding(s) in Company
2nd Mar 20097:00 amRNSAIB 2008 Preliminary Results - Part 2
2nd Mar 20097:00 amRNSAIB 2008 Preliminary Results - Part 1
19th Feb 20093:15 pmRNSTrading Statement
13th Feb 20094:40 pmRNSSecond Price Monitoring Extn
13th Feb 20094:35 pmRNSPrice Monitoring Extension
12th Feb 20097:00 amRNSRecapitalisation of AIB & Bank of Ireland
12th Feb 20097:00 amRNSAllied Irish Banks, p.l.c. Capital Update
11th Feb 20092:41 pmRNSDirector/PDMR Shareholding
6th Feb 20097:00 amRNSMM - Cancellation Notice
30th Jan 20094:40 pmRNSSecond Price Monitoring Extn
30th Jan 20094:35 pmRNSPrice Monitoring Extension
26th Jan 200912:03 pmRNSDirector Declaration
26th Jan 200911:48 amRNSRule 8.3- (Aer Lingus Group Plc)
23rd Jan 200911:46 amRNSRule 8.3- (Aer Lingus Group Plc)
22nd Jan 20099:25 amRNSDirectorate Change
20th Jan 200911:50 amRNSRule 8.3- (Aer Lingus Group Plc)
14th Jan 200911:35 amRNSRule 8.3- Aer Lingus Group Plc
13th Jan 20094:57 pmRNSDirector/PDMR Shareholding
8th Jan 200911:40 amRNSDirector Declaration
23rd Dec 200812:57 pmRNSHolding(s) in Company
22nd Dec 200811:53 amRNSRule 8.3- Aer Lingus Group plc
22nd Dec 20087:00 amRNSAIB agrees capital measures
19th Dec 200811:51 amRNSRule 8.3- (Aer Lingus Group plc)
18th Dec 20084:21 pmRNSDirector/PDMR Shareholding
18th Dec 200812:20 pmRNSRule 8.3- (Aer Lingus Group plc)
16th Dec 20084:25 pmRNSHolding(s) in Company
15th Dec 20083:48 pmRNSHolding(s) in Company
15th Dec 200812:12 pmRNSRule 8.3- Irish Continental Group plc
15th Dec 200812:10 pmRNSRule 8.3- Aer Lingus Group plc
11th Dec 20085:32 pmRNSDirector/PDMR Shareholding
11th Dec 200812:19 pmRNSDirectorate Change
3rd Dec 200811:57 amRNSRule 8.3- Irish Continental Group plc
2nd Dec 200812:19 pmRNSCall Option
2nd Dec 200812:01 pmRNSRule 8.1- (Aer Lingus Group plc)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.